Dukes Iain D.
- SEC CIK
- 0001681955
No open-market purchases or sales filed in the past year.
Current role at each company
- TRAW Traws Pharma, Inc.Chief Executive Officeras of Jul 14, 2026
- IOVA Iovance Biotherapeutics, Inc.Directoras of Jun 18, 2026
- Lomond Therapeutics Holdings, Inc.CEO and Chairmanas of Nov 5, 2024
- IMA ImageneBio, Inc.Directoras of Jun 10, 2024
- THRX Theseus Pharmaceuticals, Inc.Directoras of Feb 14, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dukes Iain D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IOVA Iovance Biotherapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 (view filing) | Feb 20 | Same day | Dukes Iain D.Director | PPurchase | +32.0K | $9.15 | +$292.8K | +145.5%54.0K after | |
| Nov 28, 2022 (view filing) | Nov 23 | 5 days | Dukes Iain D.Director | PPurchase | +10.0K | $6.10 | +$61.0K | +83.3%22.0K after |